Skip to main content

News

By Dave Muoio | 03:06 pm | November 04, 2020
The tool was "100% accurate" when spotting cases among asymptomatic individuals, the researchers wrote, and could be deployed as a low-cost prescreener to support diagnostic testing efforts.
By Sara Mageit | 12:44 pm | November 04, 2020
The launch coincides with 54gene being appointed as a country partner in a global registry study of healthcare workers exposed to COVID-19.
By Dave Muoio | 04:26 pm | November 03, 2020
Outcomes from the randomized controlled trial were presented today at a virtual conference. The company and its research partners say this study differs from others due to its size and length.
By Laura Lovett | 03:54 pm | November 03, 2020
The company is releasing its research on mapping biomarkers for depression. 
By Dave Muoio | 01:29 pm | November 03, 2020
Also: Digital therapeutics company Palo Alto Health Sciences reports $9.1 million; Adherium gains new support from investment firm Viburnum.
By Sophie Porter | 01:11 pm | November 03, 2020
  The accelerator project has created over 200 jobs in life sciences and medtech companies in the last five years, creating opportunity in an otherwise very expensive field
By Mallory Hackett | 12:28 pm | November 03, 2020
The company hopes to reach new and existing customers with the addition of LifeDojo’s digital tools that can lead to better health outcomes and lower associated costs.
By Sophie Porter | 07:48 am | November 03, 2020
The new report from Research2Guidance (R2G) highlights the current state of the most developed digital health sector, locating service expansion into comorbidities as a key trend.
By Dave Muoio | 04:16 pm | November 02, 2020
The fitness apparel brand said it will be throwing all its weight behind the MapMyFitness platform in an effort to better focus its digital strategy.